Nuvalent, Inc. 4

Henry E. Pelish, CSO of Nuvalent, Inc., sold 2,111 shares of Class A Common Stock at about $123.81 per share in a Rule 10b5-1 sell-to-cover transaction.

On 2026-07-09, Nuvalent, Inc. Chief Scientific Officer Henry E. Pelish sold 2,111 shares of Class A Common Stock at an average price of approximately $123.81 per share, for total proceeds of about $261,000. The transaction was executed pursuant to a pre-arranged durable Rule 10b5-1 sell-to-cover instruction letter dated December 6, 2023, specifically to satisfy tax withholding obligations arising from the vesting of previously granted equity awards, and is therefore a routine, non-discretionary sale tied to compensation. Following this sale, Pelish continued to hold 63,493 shares of Nuvalent common stock, which, based on the transaction price, represent an equity stake valued at roughly $7.86 million.

Filing Facts

CIK

1861560

Ticker

NUVL

Form

4

Source Type

fda

Accession

0002029477-26-000008

Alert Tier

5